← Every company
Jazz Pharmaceuticals PLC Executive Compensation
What Jazz Pharmaceuticals PLC's board awarded its chief executive, and what the same award was worth once the share price had moved. Companies have had to disclose both since 2023, and they routinely differ by several times over.
JAZZ on carbonthat →Latest year
2024
4 years disclosed
Awarded that year
$15.5M
Actually paid
$17.3M
after revaluation
Across every year
$63.9M
$46M actually paid
Year by year
Newest first. A negative figure means the award lost more than its whole value over the year.
| Year | Awarded | Actually paid |
|---|---|---|
| 20241.1×$100 → $75 | $15.5M | $17.3M |
| 2023-0.2×$100 → $75 | $15.3M | -$2.5M |
| 20221.5×$100 → $97 | $17.3M | $26.3M |
| 20210.3×$100 → $77 | $15.7M | $4.9M |
Source: pay-versus-performance disclosures, read from SEC XBRL company facts. "Compensation actually paid" is a revaluation of awards that may never vest, not cash received — a board that awards shares and watches them halve discloses the second, smaller figure, and that is the disclosure working rather than a pay cut. Only the years a company tagged where the SEC's data can reach them appear here.
More on JAZZ
Company overviewEverything on JAZZ in one place, with the price.SEC filingsWhat JAZZ's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat JAZZ's own officers and directors buy and sell.Planned salesSales JAZZ insiders have filed notice of.LobbyingWhat JAZZ spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on JAZZ's account, and who they worked for.Federal contractsWhat federal agencies pay JAZZ.PatentsWhat JAZZ is filing at the patent office.